Quick Takeaways
- RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13D for SPYGLASS PHARMA, INC. Common Stock, $0.00001 par value per share.
- Disclosed ownership: 24%.
- Date of event: 09 Feb 2026.
Quoteable Key Fact
"RA CAPITAL MANAGEMENT, L.P. disclosed 24% ownership in SPYGLASS PHARMA, INC. Common Stock, $0.00001 par value per share on 09 Feb 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RA Capital Management, L.P. | 24% | 8,022,639 | 0 | 8,022,639 | /s/ Peter Kolchinsky | By Peter Kolchinsky, Authorized Signatory | 0001346824 |
| Peter Kolchinsky | 24% | 8,022,639 | 0 | 8,022,639 | /s/ Peter Kolchinsky | Peter Kolchinsky | 0001384859 |
| Rajeev Shah | 24% | 8,022,639 | 0 | 8,022,639 | /s/ Rajeev Shah | Rajeev Shah | 0001619841 |
| RA Capital Healthcare Fund, L.P. | 18% | 5,966,439 | 0 | 5,966,439 | /s/ Peter Kolchinsky | By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager | 0001315082 |
| RA Capital Nexus Fund III, L.P. | 6.2% | 2,054,678 | 0 | 2,054,678 | /s/ Peter Kolchinsky | By RA Capital Nexus Fund III GP, LLC, its General Partner, By Peter Kolchinsky, Manager | 0001883840 |